u/cesar_ivaturi

Wrote the date on the vial as well as the concentration after losing track of which one was opened first.

What concentration did you actually reconstitute at, rather than what did you intend to?

Asked WWB what volume they reconstitute to for their own stability testing and they answered in one line. Useful thing to know.

Which trial, and which arm?

What was the discontinuation rate?

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

Spent an evening with the appendix tables and found the subgroup detail that the entire thread had been speculating about.

Not convinced. Cross-trial comparison between two programmes with different populations and designs is not a comparison.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

registry entry, protocol, publication — three different documents

Net peptide content is the fraction of the powder that is actually peptide once counterion, water and residual solvent are accounted for. A 99% pure acetate salt can still be about 85% peptide by mass.

I would not round that figure. At 10mg/mL a rounding error of two units is a real fraction of the intended amount.

Argued for a week about a result and then read the limitations section, which conceded most of my opponent’s point.

Yes. The structure of the document matters at least as much as the number printed on it.

Yes, and the dead-space point is worth repeating: it is small, it is real, and it is the same for every draw.

How fast was the escalation in that protocol?

Is that intention-to-treat or completers?

Adding the check nobody runs — the registered protocol is public and takes two minutes to compare.

That delay was at clearance, not with the carrier. The lane table separates them for exactly this reason.

Aim the stream down the wall of the vial rather than into the cake. Reconstitution is a solubility problem, not a mixing problem, and mechanical shear does nothing helpful.

Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.

identity and quantity are two questions and most documents answer one

Did you ask for the batch-specific document, or is this the catalogue one?

Net peptide content is the fraction of the powder that is actually peptide once counterion, water and residual solvent are accounted for. A 99% pure acetate salt can still be about 85% peptide by mass.

a seizure notice is a document with a process attached, read it

a hold is not a seizure and people conflate them constantly

Correcting myself upthread: the guidance I quoted was superseded last year.

write the concentration on the vial in marker, that is the whole post

Nothing on this board is legal advice. Where a notice carries a deadline or a consequence, that is a matter for somebody qualified in your own jurisdiction.

chromatogram or it did not happen

Cardiovascular outcome trials are powered for events, not for weight, and are typically run in a different population with different inclusion criteria. Reading a weight number out of one is reading a secondary endpoint.

the supplier cannot reverse it and neither can you

Reconstituted at 2mL when I meant to use a different volume. Caught it because the units looked wrong on the barrel. Now I write 2.5mg/mL on the glass before I put the cap back.

research material is not approved for human use, which is why the clinical record here is thin